Trial
NCT01324635
Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
Novartis
Condition
Recurrent Glioma
Intervention
Panobinostat
Why stopped
Arm A - reached goal; Arm B - poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-02